Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 -2.616M
March 31, 2026 -4.190M
December 31, 2025 -1.319M
September 30, 2025 1.513M
June 30, 2025 -5.933M
March 31, 2025 -3.929M
December 31, 2024 -9.847M
September 30, 2024 -5.846M
June 30, 2024 -1.468M
March 31, 2024 -7.405M
December 31, 2023 0.4107M
September 30, 2023 -12.97M
June 30, 2023 -7.433M
March 31, 2023 -12.36M
December 31, 2022 -7.498M
September 30, 2022 2.474M
June 30, 2022 -11.38M
Date Value
March 31, 2022 -11.74M
December 31, 2021 -14.26M
September 30, 2021 -1.368M
June 30, 2021 -7.125M
March 31, 2021 -11.30M
December 31, 2020 -12.08M
September 30, 2020 -7.002M
June 30, 2020 -2.086M
March 31, 2020 -8.216M
December 31, 2019 -4.584M
September 30, 2019 -10.38M
June 30, 2019 -7.428M
March 31, 2019 -7.917M
December 31, 2018 -3.369M
September 30, 2018 -5.138M
June 30, 2018 -4.790M
March 31, 2018 -3.986M

Free Cash Flow Definition

Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

View Free Cash Flow (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow (Quarterly) Benchmarks

View Free Cash Flow (Quarterly) Benchmarks
Start Trial
Biodexa Pharmaceuticals Plc --
Mereo BioPharma Group Plc -6.049M
BioNTech SE -52.17M
Silence Therapeutics Plc 1.548M
Compass Pathways Plc -40.37M